Research & Education

About Us

Membership

Information on committees, committee involvement and how to become a committee member is located on the Committees Page and Committee Profiles Page.

Background:

The Pathology Committee was set up in 1982 and has advanced from being a small unfunded group of IASLC members to a body of up to 26 members with funding from the IASLC for meetings and projects that pertain to its mission statement. It is an active working group of like-minded individuals who produce guidelines and publications either for the IASLC alone or in conjunction with other organizations such as the World Health Organization (WHO), as well as participating in research and service development on behalf of the IASLC. This work is undertaken through various working parties that members are expected to join, based on their individual areas of expertise. The committee generally meets face to face twice a year; once at the annual WCLC United States and Canadian Academy of Pathology meeting and IASLC World Conference on Lung Cancer.

Purpose:

In 1983, the purpose of the panel was to:

  • Encourage research activities concerning surgical and experimental pathology of lung cancer.
  • Define a more exact histopathic interpretation and classification of lung tumors within the IASLC.
  • Offer individuals and study groups a panel evaluation of histologic/cytologic material from lung cancer to make a uniform basis for comparing clinical and paraclinical studies from the several investigations within IASLC.
  • Provide postgraduate training education in lung cancer pathology.

In 2005, the purpose of the panel was modified to:

  • Provide international leadership in the clinical and scientific aspects of lung cancer pathology
  • Support the organization on the IASLC: projects, publications, meetings
  • Be integrated with other specialties: surgery, oncology, radiation therapy and molecular biology
  • Play a central role in major publications in the field of lung cancer and other thoracic tumors
History:

The development and role of the Pathology Committee within the IASLC has been an evolution, with large parts being intimately associated with the development of lung cancer classification. After committee members published the 1981 WHO classification on lung tumors, a proposal was made to the IASLC Board to form an official Pathology Panel. On September 29, 1982, the Pathology Panel was approved by the IASLC Board and General Assembly.

Since this time, committee members published the third (1999 and 2004), and fourth (2015) editions of the WHO classifications on lung tumors and the WHO Book on pathology and genetics of tumors of lung, pleura, thymus and heart (2004). They were also responsible for defining and refining the classifications of small-cell carcinoma and adenocarcinoma subtypes. With recent advances on molecular diagnoses in lung cancer, the committee has also assumed leadership roles in the development of guidelines and standards on molecular testing for lung cancer.

The Pathology Committee contributes to research, education and practice in clinical management of lung cancer patients. They continue to pave the way for more accurate diagnosis, molecular characterization of tumor and effective targeted therapy. As the molecular genotype and phenotype of different histologic types of lung cancers are being deciphered, there is an expectation that the IASLC Pathology Committee will continue to lead in improving lung cancer diagnosis for better survival outcome of lung cancer patients.

List of Chairmen Since 1982:
  • 1982 to 91:

Mary Matthews

USA

  • 1991 to 98:

Fred Hirsch

Denmark

  • 1999 to 05:

William D. Travis

USA

  • 2005 to 09:

Elisabeth Brambilla

France

  • 2009 to 11:

Masayuki Noguchi

Japan

  • 2011 to 13:

Ming-Sound Tsao

Canada

  • 2013 to 15:

Andrew Nicholson

United Kingdom

  • 2015 to 17:

Yasushi Yatabe

Japan

  • 2017 to present

Ignacio Wistuba

USA

Current Members:
  • Ignacio Wistuba

USA

Chair

  • Yasushi Yatabe

Japan

Past Chair

  • Masayuki Noguchi

Japan

Board Liaison

  • Fred Hirsch

USA

Committee Member

  • Murry Wynes

USA

Staff Liaison

  • Mary Beth Beasley

USA

Committee Member

  • Alain Borczuk

USA

Committee Member

  • Johan Botling

Sweden

Committee Member

  • Lukas Bubendorf

Switzerland

Committee Member

  • Gang Chen

China

Committee Member

  • Teh-Ying Chou

Taiwan

Committee Member

  • Jin-Haeng Chung

South Korea

Committee Member

  • Sanja Dacic

USA

Committee Member

  • Keith Kerr

United Kingdom

Committee Member

  • Sylvie Lantuejoul

France

Committee Member

  • Mari Mino-Kenudson

USA

Committee Member

  • Andre Moreira

USA

Committee Member

  • Andrew Nicholson

United Kingdom

Committee Member

  • Giuseppe Pelosi

Italy

Committee Member

  • Claudia Poleri

Argentina

Committee Member

  • Natasha Rekhtman

USA

Committee Member

  • Anja Roden

USA

Committee Member

  • Prudence Russell

Australia

Committee Member

  • Lynette Sholl

USA

Committee Member

  • Erik Thunnissen

Netherlands

Committee Member

  • Ming Tsao

Canada

Committee Member

  • Akihiko Yoshida

Japan

Committee Member

  • Fernando Lopez-Rios

Spain

Committee Member

  • Mauro Papotti

Italy

Committee Member

  • Elisabeth Brambilla

France

Emeritus Member

  • Masayuki Noguchi

Japan

Emeritus Member

  • William Travis

USA

Emeritus Member

  • Dongmei Lin

China

Observer

  • Wendy Cooper

Australia

Observer

  • David Hwang

Canada

Observer

  • Deepali Jain

India

Observer

  • John Longshore

USA

Observer

  • Yuko Minami

Japan

Observer

  • Noriko Motoi

Japan

Observer